Lasioglossin LL-II

General Information


DRACP ID  DRACP04686

Peptide Name   Lasioglossin LL-II

Sequence  VNWKKILGKIIKVAK

Sequence Length  15

UniProt ID  C0HK43 

PubChem CID  Not available

Origin  Lasioglossum laticeps

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Amidation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H148N22O17

Absent amino acids  CDEFHMPQRSTY

Common amino acids  K

Mass  198815

Pl  11.4

Basic residues  5

Acidic residues  0

Hydrophobic residues  8

Net charge  5

Boman Index  -155

Hydrophobicity  21.33

Aliphatic Index  149.33

Half Life 
  Mammalian: 7.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  392.86

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23159628

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 19591185

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.